TherapeuticsMD Inc.
Organization details
- Legal name
- TherapeuticsMD Inc.
- Former names
- AMHN, Inc. Croff Enterprises Inc Croff Oil Co
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Nevada
- Headquarters city
- Boca Raton
- Headquarters state / province
- Florida
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- TXMD
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0000025743
- EIN
- 87-0233535
Board of directors
-
Cooper C. Collins · DirectorSince 2023
-
David Efraim Rosen · DirectorSince 2023
-
Gail K. Naughton · DirectorSince 2023
-
Tommy G. Thompson · DirectorSince 2023
Director election results
Annual meeting of December 15, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
98.5%
-
99.2%
-
99.5%
Board connections
2 of this board's directors also sit on 4 other boards. 3 are in the same sector.
-
Cel-Sci Corporation Same sectorvia Gail K. Naughton
- via Tommy G. Thompson
-
Scilex Holding Company Same sectorvia Tommy G. Thompson
-
United Therapeutics Corporation Same sectorvia Tommy G. Thompson
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $14,028
- 1 purchase by 1 insider
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 23, 2025 | Tommy G. Thompson Director | Open-market purchase | +8,400 | $1.67 | $14,028 |
| Apr 14, 2025 | Tommy G. Thompson Director | Open-market purchase | +325 | $1.00 | $325 |
| Apr 14, 2025 | Walker Marlan D Officer (Chief Executive Officer) | Open-market purchase | +490 | $1.00 | $490 |
| Apr 10, 2025 | Walker Marlan D Officer (Chief Executive Officer) | Open-market purchase | +1,167 | $0.86 | $1,004 |
| Apr 9, 2025 | Walker Marlan D Officer (Chief Executive Officer) | Open-market purchase | +1,136 | $0.87 | $988 |
| Feb 18, 2025 | Cooper C. Collins Director | Option exercise | +8,500 | — | — |
| Feb 18, 2025 | Gail K. Naughton Director | Option exercise | +8,500 | — | — |
| Feb 18, 2025 | Tommy G. Thompson Director | Option exercise | +8,500 | — | — |
| Feb 18, 2025 | Walker Marlan D Officer (Chief Executive Officer) | Option exercise | +3,467 | — | — |
| Feb 18, 2025 | Walker Marlan D Officer (Chief Executive Officer) | Option exercise | +2,311 | — | — |
| Feb 18, 2025 | Walker Marlan D Officer (Chief Executive Officer) | Option exercise | +770 | — | — |
| Feb 18, 2025 | Walker Marlan D Officer (Chief Executive Officer) | Option exercise | +1,733 | — | — |
| Aug 22, 2024 | Cooper C. Collins Director | Open-market purchase | +4,094 | $1.73 | $7,083 |
| Aug 21, 2024 | Cooper C. Collins Director | Open-market purchase | +1,200 | $1.70 | $2,040 |
| Dec 7, 2023 | Walker Marlan D Officer (Chief Executive Officer) | Open-market sale | −4,550 | $2.24 | $10,192 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about TherapeuticsMD Inc.
How many directors are on TherapeuticsMD Inc.'s board?
TherapeuticsMD Inc.'s board has 4 directors: Cooper C. Collins, David Efraim Rosen, Gail K. Naughton and Tommy G. Thompson.
Are TherapeuticsMD Inc. insiders buying or selling shares?
Over the last 12 months, TherapeuticsMD Inc. insiders bought $14,028 of shares in 1 purchase and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="therapeuticsmd-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.